Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro

Oncology Reports

Volumn 12, Issue 3, 2004, Pages 659-662

  Lu, Qing Yi ^a   Sartippour, Maryam R ^a,b   Brooks, Mai N ^a,b   Zhang, Qifeng ^a   Hardy, Mary ^a   Go, Vay Liang ^a   Li, Frederick P ^c   Heber, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Alternative medicine; Angiogenesis; Breast cancer; Cancer prevention; Ganoderma lucidum

Indexed keywords

ALCOHOL; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; PLANT EXTRACT;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CHROMATOGRAPHY; CYTOLOGY; DOSE RESPONSE; ENDOTHELIUM CELL; FUNGUS SPORE; GANODERMA LUCIDUM; HUMAN; IN VITRO STUDY; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UMBILICAL VEIN;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELLS, CULTURED; CHROMATOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENDOTHELIAL CELLS; ETHANOL; HUMANS; PLANT EXTRACTS; REISHI; SPORES, FUNGAL; UMBILICAL VEINS;

EID: 7744233551     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.3.659     Document Type: Article

References (29)

1. Wasser SP and Weis AL: Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 19: 65-96, 1999. (Pubitemid 29062102)
2. Jones K: Reishi mushroom ancient medicine in modern times. Alter Complementary Ther 4: 256-266, 1998.
3. Yun TK: Update from Asia. Asian studies on cancer chemoprevention. Ann NY Acad Sci 889: 157-192, 1999.
4. Shiao M: Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities and pharmacological functions. Chem Rec 3: 172-180, 2003.
5. Zhang HN and Lin ZB: Hypoglycemic effect of Ganoderma lucidum polysaccharides. Acta Pharmacol Sin 25: 191-195, 2004.
6. Lee SY and Rhee HM: Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem Pharm Bull 38: 1359-1364, 1990. (Pubitemid 20290836)
7. Bao X, Fang J and Li X: Structural characterization and immunomodulating activity of a complex glucan from spores of Ganoderma lucidum. Biosci Biotechnol Biochem 65: 2384-2391, 2001. (Pubitemid 33615699)
8. Min BS, Nakamura N, Miyashiro H, Bae KW and Hattori M: Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull 46: 1607-1612, 1998. (Pubitemid 28531023)
9. Hu H, Ahn NS, Yang X, Lee YS and Kang KS: Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102: 250-253, 2002. (Pubitemid 35222292)
10. Sliva D, Labarrere C, Slivova V, Sedlak M, Lloyd FP Jr and Ho NW: Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298: 603-612, 2002. (Pubitemid 35333701)
11. Ghafar MA, Golliday E, Bingham I, Mansukhani MM, Anastasiadis AG and Katz AE: Regression of prostate cancer following administration of genistein combined polysaccharide (GCP™), a nutritional supplement: a case report. J Altern Complement Med 8: 493-497, 2002. (Pubitemid 34994544)
12. Gao Y, Zhou S, Jiang W, Huang M and Dai X: Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 32: 201-215, 2003. (Pubitemid 36962040)
13. Sliva D, Sedlak M, Slivova V, Valachovicova T, Lloyd FP Jr and Ho NW: Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med 9: 491-497, 2003. (Pubitemid 37051539)
14. Min BS, Gao JJ, Nakamura N and Hattori M: Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull 48: 1026-1033, 2000. (Pubitemid 30485402)
15. Zhu HS, Yang XL, Wang LB, Zhao DX and Chen L: Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell Biol Toxicol 16: 201-206, 2000.
16. Liu X, Yuan JP, Chung CK and Chen XJ: Antitumor activity of the sporoderm-broken germinating spores of Ganoderma lucidum. Cancer Lett 182: 155-161, 2002. (Pubitemid 34621179)
17. Bao X, Liu C, Fang J and Li X: Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohydr Res 332: 67-74, 2001. (Pubitemid 32441606)
18. Bao XF, Zhen Y, Ruan L and Fang IN: Purification, characterization and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum. Chem Pharm Bull 50: 623-629, 2002. (Pubitemid 41694930)
19. Yeung HW, Lu QY, Zhang Q and Go VLW: Chemical and biochemical basis of the potential anti-tumor properties of Ganoderma lucidum. Curr Top Nutraceutical Res 2: 67-73, 2004.
20. Kimura Y, Taniguchi M and Baba K: Antitumor and anti-metastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res 22: 3309-3318, 2002. (Pubitemid 36070107)
21. Lee S, Park S, Oh JW and Yang C: Natural inhibitors for protein prenyltransferase. Planta Medica 64: 303-308, 1998. (Pubitemid 28234264)
22. Ito H, Naruse S and Shimura K: Studies on antitumor activity of basidiomycete polysaccharides: VII. Antitumor effect of the polysaccharide preparations from Ganoderma lucidum on mouse sarcoma 180. Mie Med J 26: 147-152, 1977. (Pubitemid 8172071)
23. Miyazaki T and Nishijima M: Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharm Bull 29: 3611-3616, 1981. (Pubitemid 12154632)
24. Miyazaki M and Nishijima M: Structural examination of an alkali-extracted, water-soluble heteroglycan of the fungus Ganoderma lucidum. Carb Res 109: 290-294, 1982.
25. Ukai S, Yokoyam S, Chihiro H and Kiho T: Structure of an alkali-soluble polysaccharide from the fruit body of Ganoderma japonicum Lloyd. Carb Res 105: 237-245, 1982.
26. Usui T, Iwasaki Y, Mizuno T, Tanaka M, Shinkai N and Arakawa M: Isolation and characterization of antitumor active B-D-glucans from the fruit bodies of Ganoderma applanatum. Carb Res 115: 273-280, 1983.
27. Maruyama H, Yamazaki K, Murotushi S, Konda C and Ikekawa T: Antitumor activity of Sarcodon aspratus (Berk.) S. Ito and Ganoderma lucidum (Fr.) Karst. J Pharmacobiodyn 12: 118-123, 1989. (Pubitemid 19083850)
28. Furusawa E, Chou SC, Furusawa S, Hirazumi A and Dang Y: Antitumor activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted Lewis lung carcinoma in syngeneic mice. Phytother Res 6: 300-304, 1992.
29. Lieu CW, Lee SS and Wang SY: The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res 12: 1211-1216, 1992.